RE:RE:RE:what's your opinion uncle leoGunner, if you are a long, then stop with the whining about "revenue is what we need." we all know the situation. There is very little revenue at this time in the development of the company. We ALL KNOW THAT. PLI has many irons in the fire in clinical trial with am immpressive result so far. Revenue will come in due coursr upon the eventual completion of the trials and FDA approvals to come. But we all know this ia a work in progress and complaining about it in the mean time is useless. Its like a racer in the middle of a race complaining why he has not already won - well you still have the ast half of the race to run! Do not worry the revenues will start rolling in but the normal time to complete trials and obtain FDA approvals has to happen first for the revenues to start rolling in. What is needed is patience. If you have none, then go buy Apple or Amazon or whatever if you must have revenue NOW! Minor delays are all part f this game, especially with the FDA.
about neing 1 1/2 months past June 5, I believe they have made it clear that the FDA wanted some more information which they are submitting ASAP, so the delay should not be too long - stop worrying and whining so much. Let them do their thing which they are doing very well in my estimation. They still expect (hope) for an approval yb the end of Q4, and if I understand correctly we are still in the running for vouchers etc. If you can't sleep at night in the meantime you should not be in this stock. It has had a multiple history of rapid large advances followed by large (`50%) retreats when the shorts figure it got too fat and then went on to recover and on to new highs. - RELAX or invest elsewhere in a mature stock with lots of revenue where you can relax - life is too short.